ENTRY       D10260                      Drug
NAME        Glucarpidase (INN);
            Glucarpidase (genetical recombination) (JAN);
            Voraxaze (TN);
            Megludase (TN)
PRODUCT     VORAXAZE (BTG International)
FORMULA     C3670H5926N10114O1140S12
EXACT_MASS  210257.3291
MOL_WEIGHT  210340.1812
SEQUENCE    MRPSIHRTAI AAVLATAFVA GTALAQKRDN VLFQAATDEQ PAVIKTLEKL VNIETGTGDA
            EGIAAAGNFL EAELKNLGFT VTRSKSAGLV VGDNIVGKIK GRGGKNLLLM SHMDTVYLKG
            ILAKAPFRVE GDKAYGPGIA DDKGGNAVIL HTLKLLKEYG VRDYGTITVL FNTDEEKGSF
            GSRDLIQEEA KLADYVLSFE PTSAGDEKLS LGTSGIAYVQ VNITGKASHA GAAPELGVNA
            LVEASDLVLR TMNIDDKAKN LRFNWTIAKA GNVSNIIPAS ATLNADVRYA RNEDFDAAMK
            TLEERAQQKK LPEADVKVIV TRGRPAFNAG EGGKKLVDKA VAYYKEAGGT LGVEERTGGG
            TDAAYAALSG KPVIESLGLP GFGYHSDKAE YVDISAIPRR LYMARRLIMD LGAGK
  TYPE      Peptide
REMARK      Therapeutic category: 3929
            ATC code: V03AF09
            Product: D10260<JP/US>
EFFICACY    Antidote (methotrexate concentrations)
COMMENT     Treatment of toxic plasma (methotrexate concentrations)
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AF Detoxifying agents for antineoplastic treatment
                 V03AF09 Glucarpidase
                  D10260  Glucarpidase (INN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               392  Antidotes
                3929  Others
                 D10260  Glucarpidase (INN); Glucarpidase (genetical recombination) (JAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10260
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10260
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10260
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10260
DBLINKS     CAS: 9074-87-7
            PubChem: 163312291
///
